e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Pulmonary hypertension: management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Variation in mortality from pulmonary hypertension by aetiology
Nesrin Mogulkoc (Izmir, Turkey), Nesrin Mogulkoc, Tarik Simsek, Sanem Nalbantgil, Meral Kayikcioglu, Yasemin Kabasakal, Hakan Kultursay
Source:
International Congress 2015 – Pulmonary hypertension: management
Session:
Pulmonary hypertension: management
Session type:
Thematic Poster Session
Number:
3788
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nesrin Mogulkoc (Izmir, Turkey), Nesrin Mogulkoc, Tarik Simsek, Sanem Nalbantgil, Meral Kayikcioglu, Yasemin Kabasakal, Hakan Kultursay. Variation in mortality from pulmonary hypertension by aetiology. Eur Respir J 2015; 46: Suppl. 59, 3788
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion: respiratory care for newborns in resource-limited settings
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Pulmonary hypertension due to lung disease – Results from COMPERA
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015
An epidemiological study of pulmonary arterial hypertension in Japan
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
Quality of life of patients with pulmonary arterial hypertension associated with congenital heart disease: The multicenter cross-sectional ACHILLE study
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
An epidemiological study of pulmonary arterial hypertension
Source: Eur Respir J 2007; 30: 104-109
Year: 2007
Characteristics of a stable and satisfactory condition in long term survivors of pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Treatment of pulmonary arterial hypertension in elderly and very elderly patients
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Pulmonary arterial hypertension patients underrepresented in clinical trials – Are they different?
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007
ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre
Source: Eur Respir J 2012; 39: 945-955
Year: 2012
Cardiopulmonary comorbidities are associated with hemodynamics in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Pulmonary hypertension associated with congenital heart disease (PH-CHD): Results from the ASPIRE registry
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Survival in pulmonary hypertension in Spain: insights from the Spanish registry},
Source: Eur Respir J 2012; 40: 596-603
Year: 2012
Pulmonary arterial hypertension: a comparison between children and adults
Source: Eur Respir J 2011; 37: 665-677
Year: 2011
Pulmonary hypertension in COPD: Prevalence and characteristics
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
Pulmonary function is associated with pulmonary artery systolic pressure in the general population: The Rotterdam study
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept